[ad_1]
The Ministry of Health and Population warned against the circulation of two adulterated drugs for the treatment of tumors and cancer in the local market, one of which provided by the General Authority of Health insurance to fight against "bad cancer".
Dr. Rasha Ziadeh, head of the Central Department of Pharmaceutical Affairs of the Ministry of Health, addressed the under-secretaries of the ministry in the health directorates of the various governorates to seize and seize the drugs Brigitta 240 mg and Avistein , after the company declared that the drug operations were deceived on the Egyptian market.
"Brigitta 240" is one of the most powerful drugs in oncology and is considered a relatively new product in the Egyptian market, according to pharmacist Mohamed Menna, pointing out that it is an antibody extracted from organisms infected by the "gene hair 2" bad cancer gene and biologically modified to produce the drug "Brigita".
He told us "at home" that "Brigitta" is one of the most powerful drugs on the market for bad cancer because it has the ability to reduce the size of the tumor in no time, not exceeding a few weeks, explaining that there is no alternative in the pharmaceutical market.
The drug "Avstin", says the pharmacist, is used in the treatment of several types of cancer, including cancers of the brain, kidneys, lungs, colon and rectum, as well as cancers of the uterus and fallopian tubes.
He badured us that to avoid being trapped in the purchase of counterfeit drugs, we must resort to hospitals with known names and whose reputation is guaranteed, and not resort to fraudulent transactions, and not buy these drugs from unreliable sources at reduced prices.
The Central Department of Pharmaceutical Affairs of the Ministry of Health has called on the undersecretaries of the governorates to hand over the representative of the company to Al-Ahraz after having made the necessary commitment not to remove the seals except in the presence of 39, one of the pharmacists inspectors and communicate the "Pharmaceutical Affairs" with the quantities thus released. Its members are pharmacy inspectors.
She also sent the chief of pharmaceutical affairs, the publication of the company producing the drug and the owner of the preparation, as well as the drug distribution companies to freeze the balances of these operations and for the return of what was sold or provided to pharmacies at the company's warehouses in all governorates of the Republic, and inform the Department of Pharmacy, Directorate of Health Affairs in the province of balances and returns.
[ad_2]
Source link
